title: An accumulation of p34cdc2 at the end of mouse oocyte growth correlates with the acquisition of meiotic competence.
abstract: Growing incompetent mouse oocytes released from follicular cells are unable to spontaneously resume meiosis in vitro. To identify the reasons for meiotic incompetence in these cells, the levels of p34cdc2/cyclin B kinase and p42MAPK between incompetent and competent oocytes were compared. p34cdc2 was present at very low levels in incompetent oocytes and accumulated abruptly at the time of meiotic competence acquisition. By contrast, cyclin B and p42MAPK were present at similar concentrations in both types of oocytes. Okadaic acid induced centrosome phosphorylation and meiotic reinitiation in incompetent oocytes, without inducing an increase in p34cdc2 concentration. However, the p34cdc2 present in incompetent oocytes was activated and all events following germinal vesicle breakdown were induced up to the formation of a metaphase I spindle including p42MAPK activation, sustained increase in p34cdc2 kinase activity, and translational activation of a dormant mRNA. We suggest that a threshold level of p34cdc2 has to be reached for meiotic reinitiation to be spontaneously triggered: competence is restricted at a point preceding MPF activation. Whatever the mechanism involved in this restriction point, i.e., subthreshold concentration of p34cdc2 and/or lack of an activator or presence of an inhibitor, it is bypassed by okadaic acid. Downstream of this point meiosis progresses up to metaphase 1, even though p34cdc2 concentration remains low.
authors.affiliation: D'epartement de Gyn'ecologie et Obst'etrique, H-opital Cantonal Universitaire de Gen'eve, Switzerland.
authors.forename: C
authors.initials: C
authors.lastname: de Vant'ery
authors.forename: A C
authors.initials: AC
authors.lastname: Gavin
authors.forename: J D
authors.initials: JD
authors.lastname: Vassalli
authors.forename: S
authors.initials: S
authors.lastname: Schorderet-Slatkine
mesh_terms: D000818:Animals; D016203:CDC2 Protein Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism; D016213:Cyclins / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004988:Ethers, Cyclic / Q000494:pharmacology; D005260:Female; D008540:Meiosis; D000090204:Mesothelin; D051379:Mice; D019950:Mitogen-Activated Protein Kinase 1; D019319:Okadaic Acid; D009865:Oocytes / Q000166:cytology* / Q000201:enzymology; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000378:metabolism
chemical_list: D016213:Cyclins; D004791:Enzyme Inhibitors; D004988:Ethers, Cyclic; C000715528:Msln protein, mouse; D019319:Okadaic Acid; D011505:Protein-Tyrosine Kinases; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D016203:CDC2 Protein Kinase; D019950:Mitogen-Activated Protein Kinase 1; D010749:Phosphoprotein Phosphatases; D000090204:Mesothelin